Old Web
English
Sign In
Acemap
>
authorDetail
>
Toshihiko Funahashi
Toshihiko Funahashi
Toyota
Psychiatry
Major depressive disorder
Medicine
Physical therapy
Discontinuation
4
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
2018
Neuropsychiatric Disease and Treatment
Taro Kishi
Kazuto Oya
Yuki Matsui
Ikuo Nomura
Kenji Sakuma
Makoto Okuya
Yuki Matsuda
Kiyoshi Fujita
Toshihiko Funahashi
Reiji Yoshimura
Nakao Iwata
Show All
Source
Cite
Save
Citations (6)
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
2017
Neuropsychiatric Disease and Treatment
Taro Kishi
Yuki Matsuda
Shinji Matsunaga
Masatsugu Moriwaki
Yoichiro Otake
Kaku Akamatsu
Tomo Okochi
Shigeki Hirano
Toshihiko Funahashi
Momoko Okuda
Hideaki Tabuse
Kiyoshi Fujita
Nakao Iwata
Show All
Source
Cite
Save
Citations (3)
A cross-sectional survey to investigate the prevalence of pain in Japanese patients with major depressive disorder and schizophrenia
2015
Comprehensive Psychiatry
Taro Kishi
Yuki Matsuda
Tomohiko Mukai
Shinji Matsunaga
Ichiro Yasue
Kiyoshi Fujita
Tomo Okochi
Shigeki Hirano
Yusuke Kajio
Toshihiko Funahashi
Kaku Akamatsu
Kei Ino
Momoko Okuda
Hideaki Tabuse
Nakao Iwata
Show All
Source
Cite
Save
Citations (10)
Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder.
2013
Neuropsychiatric Disease and Treatment
Kei Nagao
Taro Kishi
Masatsugu Moriwaki
Kiyoshi Fujita
Shigeki Hirano
Yoshio Yamanouchi
Toshihiko Funahashi
Nakao Iwata
Show All
Source
Cite
Save
Citations (5)
1